 Enveric Biosciences NASDAQ:ENVB Inc announced that the companys first four Patent Cooperation Treaty PCT applications for the tryptamine family of novel molecules have been published by the World Intellectual Property Organization WIPO. The Naples, Florida-based neuroscience company developing psychedelic-inspired mental health medicines said additional PCT patent applications are expected to be published over the coming months. 